Your session is about to expire
← Back to Search
Indirect Calorimetry Device
Indirect Calorimetry Devices for Mechanically Ventilated Children
N/A
Recruiting
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age > 10 years AND weight > 10kg
PEEP < 8
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour/participant
Awards & highlights
Study Summary
This trial will compare the Q-NRG+ indirect calorimetry device to the Vmax Encore indirect calorimetry device to see if they provide similar minute-to-minute measurements of oxygen consumption and carbon dioxide production.
Who is the study for?
This trial is for children over 10 years old and weighing more than 10kg who are on mechanical ventilation with specific settings. They must not have severe lung leaks, be unstable in their blood pressure, or be receiving end-of-life care.Check my eligibility
What is being tested?
The study is testing the Q-NRG+ device against the standard V(max) Encore device to measure oxygen consumption and carbon dioxide production in ventilated children to see if they agree on results.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring devices, there are minimal expected side effects related directly to the use of these devices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 10 years and weigh more than 10kg.
Select...
My breathing support settings are low.
Select...
My child is on a ventilator through a tube or tracheostomy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 hour/participant
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour/participant
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Calculated total testing time, including calibration, required to complete a steady state indirect calorimetry measurement using the Q-NRG+ device and the V(max) Encore.
Mean bias and limits of agreement between measured oxygen consumption (VO2) and carbon dioxide elimination (VCO2) in mechanically ventilated children assessed using the Q-NRG+ indirect calorimetry device and the V(max) Encore indirect calorimetry device.
Trial Design
2Treatment groups
Experimental Treatment
Group I: V(max) Encore Indirect Calorimetry DeviceExperimental Treatment1 Intervention
V(max) Encore device, currently institution's standard device, will be compared to Q-NRG+ device in each enrolled patient in subsequent, alternating fashion.
Group II: Q-NRG+ Indirect Calorimetry DeviceExperimental Treatment1 Intervention
Q-NRG+ device will be compared to current V(max) device in each enrolled patient in subsequent, alternating fashion.
Find a Location
Who is running the clinical trial?
Boston Children's HospitalLead Sponsor
761 Previous Clinical Trials
5,579,690 Total Patients Enrolled
Nilesh M Mehta, MDStudy DirectorBoston Children's Hospital
2 Previous Clinical Trials
2,014 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My doctor plans to measure my metabolism and believes research is safe for me.I am older than 10 years and weigh more than 10kg.I currently have a chest tube due to an air leak.My primary doctor has not approved me joining the trial.I do not have severe low blood pressure or need multiple medications to increase my blood pressure.My breathing support settings are low.My child is on a ventilator through a tube or tracheostomy.You need to be on ECMO support.You are receiving care for a terminal illness.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Q-NRG+ Indirect Calorimetry Device
- Group 2: V(max) Encore Indirect Calorimetry Device
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger